Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 24 October, 2006 and appeared in  Issue 335

Metformin Exposure During First Trimester Seen Safe for Fetus

Metformin taken by women with polycystic ovary syndrome (PCOS) during the first trimester of pregnancy does not appear to increase the risk of major fetal malformations, and may have a significant protective effect.
Advertisement
Metformin is used for the treatment of infertility in women with PCOS, yet the safety of the biguanide for the fetus has not been established, Dr. Gideon Koren of The Hospital for Sick Children in Toronto, Ontario, and colleagues point out. The other biguanide, phenformin, has been shown to be teratogenic.

Dr. Koren and colleagues conducted a meta-analysis of eight randomized, controlled studies of metformin taken during the first trimester of pregnancy by a total of nearly 500 women with either PCOS or diabetes.

From the pooled data, the malformation rate in the treatment group was 1.7% compared with 7.2% in disease-matched controls who did not receive metformin.

The researchers found that "after adjustment for publication bias, metformin was associated with a statistically significant protective effect of 57%" against major malformations in the fetus.

In their paper, the investigators caution that the data establishing safety of metformin in pregnancy is still limited. This study considered only major malformations of the fetus. Other studies assessing the incidence of spontaneous abortion, stillbirth, minor abnormalities, intrauterine growth retardation and preterm labor still need to be conducted.

Fertil Steril 2006;86:658-663.

==========================

Advertisement
Do you have patients in pain? Over 4,800 Anodyne Therapy Care Providers are increasing circulation and reducing pain for thousands of patients per month. To find out how you can help your patients get back to life, click here.
http://www.diabetesincontrol.com/annodyne/anodyne10_31_01.php

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 24 October, 2006 and appeared in  Issue 335

Past five issues: Diabetes Clinical Mastery Series Issue 85 | Issue 626 | Special Edition - Getting Patients on Track | Diabetes Clinical Mastery Series Issue 84 | Issue 625 |

 
Diabetes In Control Advertisers
 
 
Cast Your Vote
Now that once-weekly GLP-1 is available, which product are you recommending for your type 2 patients?

Navigate Diabetes In Control
Announcement:



Search Articles On Diabetes In Control